Dennis Plenker
Cold Spring Harbor Laboratory · 200 works · 4,510 citations · h-index 23
Top works
- Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
- Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer
- CD74–NRG1 Fusions in Lung Adenocarcinoma
- Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors
- Overcoming EGFRG724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors
- Structural Alterations of MET Trigger Response to MET Kinase Inhibition in Lung Adenocarcinoma Patients
- Cell-Autonomous and Non–Cell-Autonomous Mechanisms of Transformation by Amplified FGFR1 in Lung Cancer
- Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer
- Patient-derived Organoid Pharmacotyping is a Clinically Tractable Strategy for Precision Medicine in Pancreatic Cancer
- Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data
- Drugging the catalytically inactive state of RET kinase in RET-rearranged tumors
- Intraductal Transplantation Models of Human Pancreatic Ductal Adenocarcinoma Reveal Progressive Transition of Molecular Subtypes
- Pancreatic Cancer Patient-derived Organoids Can Predict Response to Neoadjuvant Chemotherapy
- Genomic Profiling Identifies Outcome-Relevant Mechanisms of Innate and Acquired Resistance to Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Lung Cancer
- Loop-Mediated Isothermal Amplification Detection of SARS-CoV-2 and Myriad Other Applications
- Organoid models for translational pancreatic cancer research
- MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I
- Opposing Effects of CREBBP Mutations Govern the Phenotype of Rubinstein-Taybi Syndrome and Adult SHH Medulloblastoma
- Loss of G2032R Resistance Mutation Upon Chemotherapy Treatment Enables Successful Crizotinib Rechallenge in a Patient With ROS1-Rearranged NSCLC
- Discovery of Inter-Domain Stabilizers—A Novel Assay System for Allosteric Akt Inhibitors